C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability   Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem cell company, today...

TreeFrog Therapeutics announces today that it has closed a first seed round of 600,000 euros with the support of regional partners in Nouvelle-Aquitaine. Winner of the i-LAB national innovation competition in 2018, the startup will industrialize a disruptive technology for the production of stem cells....